{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:13:46Z","timestamp":1773260026554,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.clon.2022.08.032","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T10:24:45Z","timestamp":1663151085000},"page":"761-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Use of Palliative Radiotherapy in the Treatment of Lung Cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"J.","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Woolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Q.","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2022.08.032_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/annonc\/mdy474","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Planchard","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib2","series-title":"National lung cancer audit","author":"Nhs Information Centre for Health and Social Care","year":"2022"},{"key":"10.1016\/j.clon.2022.08.032_bib3","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2022.08.032_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2022.08.032_bib5","series-title":"Overview | Lung cancer: diagnosis and management | Guidance","year":"2019"},{"key":"10.1016\/j.clon.2022.08.032_bib6","author":"Cancer Research Uk"},{"key":"10.1016\/j.clon.2022.08.032_bib7","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.cllc.2018.01.007","article-title":"Non-small-cell lung cancer with brain metastasis at presentation","volume":"19","author":"Waqar","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.23361","article-title":"Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI)","volume":"112","author":"Seute","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"Shin","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","article-title":"Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis","volume":"34","author":"Johung","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jtho.2018.07.001","article-title":"The incidence of brain metastases in stage IV ROS1-rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib","volume":"13","author":"Patil","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0360-3016(85)90307-4","article-title":"Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial","volume":"11","author":"Simpson","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0360-3016(88)90007-7","article-title":"A\u00a0randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung","volume":"14","author":"Teo","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.1991.62","article-title":"Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party","volume":"63","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.1992.196","article-title":"randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party","volume":"65","author":"A Medical Research Council (Mrc)","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0169-5002(95)00487-4","article-title":"Palliative radiation for stage 3 non-small cell lung cancer \u2013 a prospective study of two moderately high dose regimens","volume":"13","author":"Abratt","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0936-6555(96)80041-0","article-title":"Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party","volume":"8","author":"Macbeth","year":"1996","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0936-6555(05)80446-7","article-title":"Palliative radiotherapy for lung cancer: two versus five fractions","volume":"9","author":"Rees","year":"1997","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1278-3218(00)88254-2","article-title":"[Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients)]","volume":"3","author":"Reinfuss","year":"1999","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.clon.2022.08.032_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0360-3016(00)00607-6","article-title":"A\u00a0palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study","volume":"48","author":"Nestle","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0360-3016(02)02989-9","article-title":"Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)","volume":"54","author":"Bezjak","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2005.03.028","article-title":"Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study","volume":"75","author":"Sundstr\u00f8m","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clon.2004.09.008","article-title":"Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules","volume":"17","author":"Erridge","year":"2005","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib24","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1200\/JCO.2005.01.685","article-title":"Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer","volume":"23","author":"Kramer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.bjc.6602477","article-title":"A\u00a0prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)","volume":"92","author":"Senkus-Konefka","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib26","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1200\/JCO.2007.15.3312","article-title":"Palliative thoracic radiotherapy for lung cancer: a systematic review","volume":"26","author":"Fairchild","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib27","first-page":"CD002143","article-title":"Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer","volume":"1","author":"Stevens","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2022.08.032_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.21037\/apm.2017.11.01","article-title":"Bleeding in cancer patients and its treatment: a review","volume":"7","author":"Johnstone","year":"2018","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clon.2022.08.032_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0360-3016(99)00540-4","article-title":"Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study","volume":"47","author":"Langendijk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prro.2011.01.005","article-title":"Palliative thoracic radiotherapy in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline","volume":"1","author":"Rodrigues","year":"2011","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib31","series-title":"Radiotherapy dose fractionation","author":"The Royal College of Radiologists","year":"2019"},{"key":"10.1016\/j.clon.2022.08.032_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/bmj.325.7362.465","article-title":"Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial","volume":"325","author":"Falk","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2022.08.032_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.7664","article-title":"Palliative radiation for advanced central lung tumors with intentional avoidance of the esophagus (PROACTIVE): a phase 3 randomized clinical trial","volume":"8","author":"Louie","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib34","series-title":"Radiotherapy for lung cancer RCR consensus statements","author":"The Royal College of Radiologists","year":"2020"},{"key":"10.1016\/j.clon.2022.08.032_bib35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1991.9.9.1618","article-title":"Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience","volume":"9","author":"Albain","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.lungcan.2012.03.010","article-title":"Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study","volume":"77","author":"Pirker","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.prro.2018.02.009","article-title":"Palliative thoracic radiation therapy for non-small cell lung cancer: 2018. Update of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Moeller","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.lungcan.2014.11.015","article-title":"Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status","volume":"87","author":"Walasek","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib39","doi-asserted-by":"crossref","first-page":"S648","DOI":"10.1016\/j.jtho.2019.08.1369","article-title":"P2.01-25 TOURIST: Thoracic Umbrella Radiotherapy Study in Stage IV NSCLC: a phase III randomized trial in development","volume":"14","author":"Woolf","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjc.1997.123","article-title":"A\u00a0phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer","volume":"75","author":"Ball","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib41","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/JTO.0b013e3181e15d33","article-title":"Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study","volume":"5","author":"Nawrocki","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/bjc.2013.466","article-title":"Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group","volume":"109","author":"Str\u00f8m","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib43","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2022.08.032_bib44","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2022.08.032_bib45","article-title":"Toxicity profile of combining PD-1\/PD-L1 inhibitors and thoracic radiotherapy in non-small cell lung cancer: a systematic review","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clon.2022.08.032_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2020.05.035","article-title":"Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"146","author":"Jung","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib47","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/cam4.3113","article-title":"Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab","volume":"9","author":"Shaverdian","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clon.2022.08.032_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.lungcan.2021.08.019","article-title":"Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005\/CRIMSON)","volume":"161","author":"Saito","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2021.05.016","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: a multi-center retrospective study","volume":"160","author":"Tsukita","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib50","first-page":"311","article-title":"Oligometastatic non-small cell lung cancer: current management","volume":"7","author":"Rom\u00e1n-Jobacho","year":"2021","journal-title":"J\u00a0Clin Transl Res"},{"key":"10.1016\/j.clon.2022.08.032_bib51","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020690","article-title":"Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer","volume":"8","author":"Conibear","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clon.2022.08.032_bib53","doi-asserted-by":"crossref","unstructured":"Ratnakumaran R., McDonald F. The management of oligometastases in NSCLC \u2013 is Stereotactic ablative radiotherapy (SABR) now standard of care? Clin Oncol. this issue. doi: 10.1016\/j.clon.2022.08.033.","DOI":"10.1016\/j.clon.2022.08.033"},{"key":"10.1016\/j.clon.2022.08.032_bib54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2022.08.032_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2022.08.032_bib56","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e21743","article-title":"Cause of mortality in patients with lung cancer and brain metastasis","volume":"38","author":"Thawani","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib57","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2022.08.032_bib58","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib59","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib61","author":"Gondi"},{"key":"10.1016\/j.clon.2022.08.032_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12885-020-07011-z","article-title":"Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) \u2013 a phase II prospective randomized multicenter trial (NOA-14, ARO 2015\u20133, DKTK-ROG)","volume":"20","author":"Grosu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jtho.2019.02.009","article-title":"Outcome of patients with non-small cell lung cancer and brain metastases treated with checkpoint inhibitors","volume":"14","author":"Hendriks","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib64","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib65","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jtho.2021.08.009","article-title":"Brain metastases in EGFR- and ALK-positive NSCLC: outcomes of central nervous system-penetrant tyrosine kinase inhibitors alone versus in combination with radiation","volume":"17","author":"Thomas","year":"2022","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib67","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2022.08.032_bib68","first-page":"CD006121","article-title":"Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases","volume":"9","author":"Patil","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2022.08.032_bib69","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21818","article-title":"Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis","volume":"106","author":"Hu","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2022.08.032_bib70","series-title":"Clinical commissioning policy: stereotactic radiosurgery\/radiotherapy for cerebral metastases","year":"2013"},{"key":"10.1016\/j.clon.2022.08.032_bib71","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2006.08.024","article-title":"Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity","volume":"81","author":"Ernst-Stecken","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib73","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2022.08.032_bib74","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2022.08.032_bib76","first-page":"CD009454","article-title":"Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases","volume":"3","author":"Soon","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2022.08.032_bib77","first-page":"CD003869","article-title":"Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases","volume":"1","author":"Tsao","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2022.08.032_bib78","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ijrobp.2020.07.2108","article-title":"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: a phase III randomized controlled trial","volume":"108","author":"Li","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib79","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2021.10.008","article-title":"Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery","volume":"112","author":"Kowalchuk","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.08.032_bib80","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib83","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib84","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib85","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1200\/JCO.2020.38.15_suppl.9068","article-title":"First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): impact of brain metastases on treatment patterns and outcomes","volume":"38","author":"Chen","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib86","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2021.06.026","article-title":"Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: a meta-analysis","volume":"162","author":"Viani","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.08.032_bib88","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13063-018-2745-x","article-title":"Whole brain radiation therapy alone versus radiosurgery for patients with 1\u201310 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial","volume":"19","author":"Bernhardt","year":"2018","journal-title":"Trials"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522003776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522003776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:51:43Z","timestamp":1760543503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655522003776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0936655522003776"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2022.08.032","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Palliative Radiotherapy in the Treatment of Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2022.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.","name":"copyright","label":"Copyright"}]}}